These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10429246)

  • 21. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct signature type I interferon responses are determined by the infecting virus and the target cell.
    Baig E; Fish EN
    Antivir Ther; 2008; 13(3):409-22. PubMed ID: 18572754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
    Baker DP; Lin EY; Lin K; Pellegrini M; Petter RC; Chen LL; Arduini RM; Brickelmaier M; Wen D; Hess DM; Chen L; Grant D; Whitty A; Gill A; Lindner DJ; Pepinsky RB
    Bioconjug Chem; 2006; 17(1):179-88. PubMed ID: 16417267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human interferons alpha, beta and omega.
    Bekisz J; Schmeisser H; Hernandez J; Goldman ND; Zoon KC
    Growth Factors; 2004 Dec; 22(4):243-51. PubMed ID: 15621727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatorial engineering to enhance amylosucrase performance: construction, selection, and screening of variant libraries for increased activity.
    van der Veen BA; Potocki-Véronèse G; Albenne C; Joucla G; Monsan P; Remaud-Simeon M
    FEBS Lett; 2004 Feb; 560(1-3):91-7. PubMed ID: 14988004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased antiviral activity of microscale-purified HuIFN alpha 8 (human interferon alpha 8) over HuIFN alpha 2b in Hep-2 cells challenged with Mengo virus.
    García JC; Ariza AM; Lasa AM; González LJ; Perez VB
    Biotechnol Appl Biochem; 2007 Nov; 48(Pt 3):159-65. PubMed ID: 17523917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human interferon-alpha species and hybrid proteins.
    Pestka S
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-4-S9-17. PubMed ID: 9208870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The carboxyterminal domains of human IFN-alpha2 and IFN-alpha8 are antigenically homologous.
    Vancová I; Kontseková E; Mucha V; Kontsek P
    J Interferon Cytokine Res; 2000 May; 20(5):455-61. PubMed ID: 10841073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation between structure and anti-viral activity in interferon system].
    Sugiyama K; Voss T; Ahorn H; Maurer-Fogy I; Barsoumian EL
    Yakugaku Zasshi; 1995 May; 115(5):390-3. PubMed ID: 7595866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure/function studies of murine interferon-alpha 1 using site-directed mutagenesis followed by in vitro synthesis.
    Lai MC; Beilharz MW; Scalzo AA; Garrett KL; Cannon JF; Boyer SJ; Swaminathan N
    Antiviral Res; 1992 May; 18(1):65-76. PubMed ID: 1329645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small Molecule Agonists for the Type I Interferon Receptor: An In Silico Approach.
    Wei L; Bello AM; Majchrzak-Kita B; Salum N; Lewis MM; Kotra LP; Fish EN
    J Interferon Cytokine Res; 2016 Mar; 36(3):180-91. PubMed ID: 26700737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human interferon-alpha A, -alpha 2, and -alpha 2(Arg) genes in genomic DNA.
    Emanuel SL; Pestka S
    J Biol Chem; 1993 Jun; 268(17):12565-9. PubMed ID: 8509397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to interferon-alpha in a mouse B-cell lymphoma involves DNA methylation.
    Reid TR; Merigan TC; Basham TY
    J Interferon Res; 1992 Apr; 12(2):131-7. PubMed ID: 1374455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling of the 3-D structure of IFN-alpha-k and characterization of its surface molecular properties.
    Miertus S; Tomasi J; Mazzanti G; Chiellini EE; Solaro R; Chiellini E
    Int J Biol Macromol; 1997 Apr; 20(2):85-95. PubMed ID: 9184940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermolecular homologies of human interferon-alpha.
    Romantsev FE; Khodarev NN; Votrin II
    Biochem Biophys Res Commun; 1992 Jul; 186(1):211-8. PubMed ID: 1632767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and cloning of interferon alpha.
    Pestka S
    Curr Top Microbiol Immunol; 2007; 316():23-37. PubMed ID: 17969442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of DNA shuffling to pharmaceuticals and vaccines.
    Patten PA; Howard RJ; Stemmer WP
    Curr Opin Biotechnol; 1997 Dec; 8(6):724-33. PubMed ID: 9425664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Forced Oscillations of DNA Bases].
    Yakushevich LV; Krasnobaeva LA
    Biofizika; 2016; 61(2):286-96. PubMed ID: 27192830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Breeding of Genes, Pathways and Genomes by Dna Shuffling.
    Stemmer WPC
    ScientificWorldJournal; 2002; 2():130-131. PubMed ID: 29973836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.